6533b861fe1ef96bd12c56a9
RESEARCH PRODUCT
520 EFFECT OF CYCLOOXYGENASE-1 POLYMORPHISMS ON URINARY 11-DEHYDROTHROMBOXANE B2 LEVELS IN PATIENTS UNDERGOING STENT IMPLANTATION PRETREATED WITH ASPIRIN
Baiba KrivmaneE. LiepinsI. UrtaneA. KnipseGustavs LatkovskisMaija DambrovaM. ZabunovaM. BerzinaN. LicisAndrejs Erglissubject
Aspirinmedicine.medical_specialtybiologybusiness.industryUrinary systemUrologyGeneral MedicineAnesthesiaInternal Medicinemedicinebiology.proteinStent implantationIn patientCyclooxygenaseCardiology and Cardiovascular Medicinebusiness11-dehydrothromboxane B2medicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2011-06-01 | Atherosclerosis Supplements |